Home High-Flow Nasal Cannula vs. Noninvasive Ventilation for Stable Chronic Respiratory Failure

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions

Stable Chronic Hypercapnic Respiratory Failure

Interventions

DEVICE

High-Flow Nasal Cannula

To compare the effects of NIV (Trilogy Evo®) and HFNC (myAirvo2®) in patients with chronic hypercapnic COPD.

DEVICE

Noninvasive Ventilation

to compare the effects of NIV (Trilogy Evo®) and HFNC (myAirvo2®) in patients with chronic hypercapnic COPD

Trial Locations (1)

Wonju Severance Christian Hospital, Wŏnju

All Listed Sponsors

lead

Wonju Severance Christian Hospital

OTHER

NCT06872801 - Home High-Flow Nasal Cannula vs. Noninvasive Ventilation for Stable Chronic Respiratory Failure | Biotech Hunter | Biotech Hunter